The rapid test method performs multiplex USP pathogen detection in 24 hours.
A newly released assay for detecting pathogens in nutraceutical products will be showcased at this year’s SupplySide West trade show by in vitro diagnostics company bioMérieux SA (Chicago). The rapid test method performs multiplex USP pathogen detection in 24 hours.
“We look forward to engaging with existing and new customers at SupplySide West and showcasing our innovative nutraceutical testing solutions,” said Ben Pascal, chief business officer with Invisible Sentinel, a bioMérieux company, in a press release. “There is an industry notion that rapid testing is not an acceptable equivalent to USP methods, and we’d like to show the industry how bioMérieux has revolutionized rapid testing methods, paving the way for the future of testing for nutraceuticals.”
The new method, called Gene-Up Nutraplex Pro, is a multiplex assay that “simultaneously detects Escherichia coli, Salmonella spp., and Staphylococcus aureus from a single universal enrichment in 24 hours.” It improves testing efficiency for challenging nutraceutical matrices while meeting the needs of USP <2002>, the company says. Gene-Up Nutraplex Pro was recently awarded the first-ever AOAC Research Institute Performance Tested Methods approval (PTM 082103) for multiple USP pathogen detection and PCR-based culture confirmation in nutraceutical products. “With this certification, Gene-Up Nutraplex Pro outperformed both FDA BAM and USP <2002>,” the firm says.
bioMérieux will discuss this and other test methods that improve precision and speed of testing for functional foods, beverages, and dietary supplements, including the automated enumeration Tempo system and immunoassay pathogen screening Vidas system, at SupplySide West.